Ingalls & Snyder LLC Vericel Corp Transaction History
Ingalls & Snyder LLC
- $2.82 Billion
- Q2 2025
A detailed history of Ingalls & Snyder LLC transactions in Vericel Corp stock. As of the latest transaction made, Ingalls & Snyder LLC holds 15,820 shares of VCEL stock, worth $539,936. This represents 0.02% of its overall portfolio holdings.
Number of Shares
15,820
Previous 16,581
4.59%
Holding current value
$539,936
Previous $740,000
9.05%
% of portfolio
0.02%
Previous 0.02%
Shares
28 transactions
Others Institutions Holding VCEL
# of Institutions
295Shares Held
54.3MCall Options Held
35.6KPut Options Held
7.7K-
Black Rock Inc. New York, NY8.06MShares$275 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.56MShares$122 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD2.81MShares$96 Million3.59% of portfolio
-
Conestoga Capital Advisors, LLC2.46MShares$84.1 Million1.56% of portfolio
-
State Street Corp Boston, MA2.44MShares$83.1 Million0.0% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $1.61B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...